Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Siderowf

Showing results (21-30 of 182) with videos related to

Pageof 19
Sort By:
International Journal of Geriatric Psychiatry|June 15, 2007
Differences in depression symptoms in patients with Alzheimer's and Parkinson's diseases: evidence from the 15-item Geriatric Depression Scale (GDS-15)Daniel Weintraub, Sharon Xie, Jason Karlawish, et al.
The Lancet. Neurology|October 20, 2023
α-synuclein seed amplification in Parkinson's disease - Authors' replyAndrew Siderowf, Luis Concha-Marambio, Kenneth Marek, et al.
Neurology|February 13, 2002
Gastrostomy insertion in ALS patients with low vital capacity: respiratory support and survivalSusan Gregory, Andrew Siderowf, Ame L Golaszewski, et al.
Annals of Neurology|March 13, 2010
Local institutional review board (IRB) review of a multicenter trial: local costs without local contextBernard Ravina, Lisa Deuel, Andrew Siderowf, et al.
Parkinsonism & Related Disorders|September 21, 2011
Screening questionnaires for parkinsonism: a systematic reviewNabila Dahodwala, Andrew Siderowf, Mona Baumgarten, et al.
Handbook of Clinical Neurology|February 16, 2023
Challenges in the study of individuals at risk for Parkinson diseaseConnie Marras, Roy N Alcalay, Andrew Siderowf, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2018
Biomarkers for cognitive impairment in Lewy body disorders: Status and relevance for clinical trialsAndrew Siderowf, Dag Aarsland, Brit Mollenhauer, et al.
Annals of Neurology|September 11, 2009
Treatment disparities in Parkinson's diseaseNabila Dahodwala, Ming Xie, Elizabeth Noll, et al.
Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology|June 11, 2008
F2 isoprostane levels in plasma and urine do not support increased lipid peroxidation in cognitively impaired Parkinson disease patientsJames Connolly, Andrew Siderowf, Christopher M Clark, et al.
Parkinsonism & Related Disorders|October 4, 2022
Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS studyPavan A Vaswani, James F Morley, Danna Jennings, et al.
Pageof 19

Showing results (21-30 of 182) with videos related to

Sort By:
Pageof 19
International Journal of Geriatric Psychiatry|June 15, 2007
Differences in depression symptoms in patients with Alzheimer's and Parkinson's diseases: evidence from the 15-item Geriatric Depression Scale (GDS-15)Daniel Weintraub, Sharon Xie, Jason Karlawish, et al.
The Lancet. Neurology|October 20, 2023
α-synuclein seed amplification in Parkinson's disease - Authors' replyAndrew Siderowf, Luis Concha-Marambio, Kenneth Marek, et al.
Neurology|February 13, 2002
Gastrostomy insertion in ALS patients with low vital capacity: respiratory support and survivalSusan Gregory, Andrew Siderowf, Ame L Golaszewski, et al.
Annals of Neurology|March 13, 2010
Local institutional review board (IRB) review of a multicenter trial: local costs without local contextBernard Ravina, Lisa Deuel, Andrew Siderowf, et al.
Parkinsonism & Related Disorders|September 21, 2011
Screening questionnaires for parkinsonism: a systematic reviewNabila Dahodwala, Andrew Siderowf, Mona Baumgarten, et al.
Handbook of Clinical Neurology|February 16, 2023
Challenges in the study of individuals at risk for Parkinson diseaseConnie Marras, Roy N Alcalay, Andrew Siderowf, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2018
Biomarkers for cognitive impairment in Lewy body disorders: Status and relevance for clinical trialsAndrew Siderowf, Dag Aarsland, Brit Mollenhauer, et al.
Annals of Neurology|September 11, 2009
Treatment disparities in Parkinson's diseaseNabila Dahodwala, Ming Xie, Elizabeth Noll, et al.
Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology|June 11, 2008
F2 isoprostane levels in plasma and urine do not support increased lipid peroxidation in cognitively impaired Parkinson disease patientsJames Connolly, Andrew Siderowf, Christopher M Clark, et al.
Parkinsonism & Related Disorders|October 4, 2022
Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS studyPavan A Vaswani, James F Morley, Danna Jennings, et al.
Pageof 19